Chronic Rhinosinusitis Trial, Recruiting (NCT03725956)

Chronic Rhinosinusitis Trial, Recruiting NCT03725956 Sponsor: University Hospital, Lille Condition: Chronic Rhinosinusitis

Printed from Voxsanity (voxsanity.com.au) — NCT03725956 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Chronic Rhinosinusitis

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You have had endoscopic sinus surgery (a procedure to clear the nasal passages) for nasal polyps that did not get better after at least 4 months of steroid medication treatment
You are covered by social insurance (health coverage)
You are willing to follow all the steps and procedures of the study for its full duration
You agree to take part and have given your consent

Who may not be able to join:

You have had previous nasal surgery for nasal polyps before this study
You have previously used a CPAP machine (a breathing device worn during sleep for sleep apnea)
You are not covered by a social security or health insurance scheme
You are unable to understand or receive information about the study (confirm with trial site)
You are not willing to sign the consent form
You are currently detained or deprived of your freedom
You are under a legal protection arrangement, such as guardianship or a similar system

⚠️ Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 27 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Geoffrey Mortuaire, MD, University Hospital, Lille

Phone: 03 20 44 56 72

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT03725956

Sponsor: University Hospital, Lille

Phase: Not Applicable

Status: Recruiting

Condition: Chronic Rhinosinusitis

Trial contact: 03 20 44 56 72

More information: https://clinicaltrials.gov/study/NCT03725956

Eligibility summary (AI generated)

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You have had endoscopic sinus surgery (a procedure to clear the nasal passages) for nasal polyps that did not get better after at least 4 months of steroid medication treatment
You are covered by social insurance (health coverage)
You are willing to follow all the steps and procedures of the study for its full duration
You agree to take part and have given your consent

Who may not be able to join:

You have had previous nasal surgery for nasal polyps before this study
You have previously used a CPAP machine (a breathing device worn during sleep for sleep apnea)
You are not covered by a social security or health insurance scheme
You are unable to understand or receive information about the study (confirm with trial site)
You are not willing to sign the consent form
You are currently detained or deprived of your freedom
You are under a legal protection arrangement, such as guardianship or a similar system

⚠️ Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 27 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

University Hospital, Lille

Registry

ClinicalTrials.gov

Start date

17 January 2019

Est. completion

1 December 2025

Where this trial is recruiting

🇫🇷 France

Primary endpoints

Change in Slow-wave sleep duration

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov